SCHEDULE: Zeo Scientifix: Wendy Grey Boosts Stake to 49.38%
Schedule 13D Amendment
Wendy Grey and Greyt Ventures, LLC have amended their Schedule 13D filing, increasing their beneficial ownership and voting power in Zeo Scientifix, Inc. to 49.38%.
Summary
- Wendy Grey and Greyt Ventures, LLC (the Reporting Persons) have filed an amendment to their Schedule 13D, updating their beneficial ownership and voting power in Zeo Scientifix, Inc.
- The Reporting Persons now beneficially own 2,117,500 shares of common stock, representing 23.88% of the class, after accounting for warrants and options.
- Additionally, the Reporting Persons hold 50 shares of Series C Preferred Stock, which grants them an additional 25.5% of the total voting power.
- The aggregate voting power held by the Reporting Persons is now 49.38%.
- This increase in stake is due to the grant of restricted shares and stock options under the Issuer's equity incentive plan.
- The filing states there are no current plans to acquire or dispose of additional shares, nor any plans for extraordinary corporate transactions, asset sales, or changes in management or capitalization.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports an increase in beneficial ownership and voting power without disclosing specific operational or financial performance details.
Positives
- Increased beneficial ownership and voting power by Wendy Grey and Greyt Ventures, LLC to 49.38% of Zeo Scientifix, Inc.
- The Reporting Persons have sole voting and dispositive power over their 2,117,500 shares of common stock.
- Restricted shares and stock options were granted under the company's equity incentive plan, indicating potential future employee/management alignment.
Negatives
- The filing does not contain any negative financial results or operational challenges.
- No information is provided regarding the company's financial performance or market position.
Risks
- While the filing states no definite plans for future transactions, the potential for future acquisitions or dispositions of shares exists, subject to Exchange Act compliance.
- The concentration of voting power (49.38%) in a single reporting person could lead to significant influence over corporate decisions.
Future Outlook
The Reporting Person has no definite plan to acquire or dispose of additional shares but may do so in the future. The board of directors may also issue additional equity awards to the Reporting Person from time to time.
Management Comments
- The Reporting Person has no definite plan to acquire or dispose of additional shares of the Issuer's common stock in open market or private transactions, but may do so in the future, subject to compliance with the Exchange Act and the rules and regulations thereunder.
- While there is no definite plan to issue additional shares of the Issuer's common stock to the Reporting Person under one or more of the Issuer's equity incentive plans, the board of directors or a committee thereof may determine to issue awards of shares of common stock under such plans to the Reporting Person from time to time in the future.
Industry Context
StockSavvy.ai notes that Schedule 13D filings typically signal a significant change in beneficial ownership, often preceding activist investor actions or strategic shifts. The substantial increase in voting power by Wendy Grey and Greyt Ventures, LLC to nearly half of the total voting power in Zeo Scientifix, Inc. warrants close observation for potential future corporate governance or strategic initiatives.
Stakeholder Impact
- Shareholders: The significant increase in voting power by a single entity may influence future corporate decisions and strategic direction.
- Management: Potential for increased scrutiny or influence from the Reporting Persons on management decisions.
- Board of Directors: The Reporting Persons' substantial voting power could impact board composition and decision-making processes.
Next Steps
- Potential future acquisition or disposition of additional shares by the Reporting Person.
- Potential future issuance of equity awards by the Issuer to the Reporting Person.
Key Dates
| Date | Description |
|---|---|
| 2022-09-16 | Original Schedule 13D filing date. |
| 2026-01-14 | Grant of 175,000 restricted shares under the Plan. |
| 2026-02-06 | Filing of Amendment No. 1. |
| 2026-04-30 | Issuer's Quarterly Report on Form 10-Q filing date. |
| 2026-06-10 | Grant of 625,000 stock options under the Plan. |
| 2026-06-12 | Date as of which common stock outstanding is reported. |
| 2026-06-15 | Issuer's Quarterly Report on Form 10-Q filed with SEC. |
| 2026-07-14 | Vesting date for 87,500 restricted shares. |
| 2026-07-24 | Date of signature for Amendment No. 2. |
Recommendation
holdThe filing indicates a significant increase in beneficial ownership and voting power, which could lead to future strategic actions. However, without specific financial performance data or clear strategic plans outlined, a 'hold' recommendation is prudent, suggesting investors monitor further developments.
Keywords
Schedule 13D, Beneficial Ownership, Voting Power, Zeo Scientifix, Wendy Grey, Greyt Ventures, Common Stock, Preferred Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.